309 related articles for article (PubMed ID: 25369131)
1. Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
van Bracht E; Versteegden LR; Stolle S; Verdurmen WP; Woestenenk R; Raavé R; Hafmans T; Oosterwijk E; Brock R; van Kuppevelt TH; Daamen WF
PLoS One; 2014; 9(11):e110813. PubMed ID: 25369131
[TBL] [Abstract][Full Text] [Related]
2. Specific targeting of tumor cells by lyophilisomes functionalized with antibodies.
van Bracht E; Stolle S; Hafmans TG; Boerman OC; Oosterwijk E; van Kuppevelt TH; Daamen WF
Eur J Pharm Biopharm; 2014 May; 87(1):80-9. PubMed ID: 24463217
[TBL] [Abstract][Full Text] [Related]
3. Lyophilisomes as a new generation of drug delivery capsules.
van Bracht E; Raavé R; Verdurmen WP; Wismans RG; Geutjes PJ; Brock RE; Oosterwijk E; van Kuppevelt TH; Daamen WF
Int J Pharm; 2012 Dec; 439(1-2):127-35. PubMed ID: 23069914
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
5. Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP.
Eggimann GA; Buschor S; Darbre T; Reymond JL
Org Biomol Chem; 2013 Oct; 11(39):6717-33. PubMed ID: 23933745
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane delivery of the cell-penetrating peptide conjugated semiconductor quantum dots.
Chen B; Liu Q; Zhang Y; Xu L; Fang X
Langmuir; 2008 Oct; 24(20):11866-71. PubMed ID: 18823093
[TBL] [Abstract][Full Text] [Related]
7. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of size-selected lyophilisomes in mice.
van Bracht E; Raavé R; Perevyazko IY; Versteeg EM; Hafmans TG; Schubert US; Oosterwijk E; van Kuppevelt TH; Daamen WF
Eur J Pharm Biopharm; 2015 Aug; 94():141-51. PubMed ID: 25953331
[TBL] [Abstract][Full Text] [Related]
9. Correction: Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
PLOS ONE Staff
PLoS One; 2015; 10(4):e0124465. PubMed ID: 25856400
[No Abstract] [Full Text] [Related]
10. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
[TBL] [Abstract][Full Text] [Related]
11. siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat.
Al Soraj M; He L; Peynshaert K; Cousaert J; Vercauteren D; Braeckmans K; De Smedt SC; Jones AT
J Control Release; 2012 Jul; 161(1):132-41. PubMed ID: 22465675
[TBL] [Abstract][Full Text] [Related]
12. Constrained and UV-activatable cell-penetrating peptides for intracellular delivery of liposomes.
Hansen MB; van Gaal E; Minten I; Storm G; van Hest JC; Löwik DW
J Control Release; 2012 Nov; 164(1):87-94. PubMed ID: 23085152
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
14. Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.
Buhl T; Braun A; Forkel S; Möbius W; van Werven L; Jahn O; Rezaei-Ghaleh N; Zweckstetter M; Mempel M; Schön MP; Haenssle HA
Exp Dermatol; 2014 Jan; 23(1):20-6. PubMed ID: 24372650
[TBL] [Abstract][Full Text] [Related]
15. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
16. TAT-modified nanosilver for combating multidrug-resistant cancer.
Liu J; Zhao Y; Guo Q; Wang Z; Wang H; Yang Y; Huang Y
Biomaterials; 2012 Sep; 33(26):6155-61. PubMed ID: 22682937
[TBL] [Abstract][Full Text] [Related]
17. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Peptide delivery into cells by using the synergistic effects of a cell-penetrating Peptide and a chemical drug to alter cell permeability.
Ma JL; Wang H; Wang YL; Luo YH; Liu CB
Mol Pharm; 2015 Jun; 12(6):2040-8. PubMed ID: 25886885
[TBL] [Abstract][Full Text] [Related]
19. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
20. Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides.
Min S; Kim K; Ku S; Park JY; Seo J; Roh S
Biotechnol Prog; 2020 Sep; 36(5):e3014. PubMed ID: 32374475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
